FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2571455808> ?p ?o ?g. }

• W2571455808 endingPage "224" @default.
• W2571455808 startingPage "1" @default.
• W2571455808 abstract "Background Fibrin sealants are used in different types of surgery to prevent the accumulation of post-operative fluid (seroma) or blood (haematoma) or to arrest haemorrhage (bleeding). However, there is uncertainty around the benefits and harms of fibrin sealant use. Objectives To systematically review the evidence on the benefits and harms of fibrin sealants in non-emergency surgery in adults. Data sources Electronic databases [MEDLINE, EMBASE and The Cochrane Library (including the Cochrane Database of Systematic Reviews, the Database of Abstracts of Reviews of Effects, the Health Technology Assessment database and the Cochrane Central Register of Controlled Trials)] were searched from inception to May 2015. The websites of regulatory bodies (the Medicines and Healthcare products Regulatory Agency, the European Medicines Agency and the Food and Drug Administration) were also searched to identify evidence of harms. Review methods This review included randomised controlled trials (RCTs) and observational studies using any type of fibrin sealant compared with standard care in non-emergency surgery in adults. The primary outcome was risk of developing seroma and haematoma. Only RCTs were used to inform clinical effectiveness and both RCTs and observational studies were used for the assessment of harms related to the use of fibrin sealant. Two reviewers independently screened all titles and abstracts to identify potentially relevant studies. Data extraction was undertaken by one reviewer and validated by a second. The quality of included studies was assessed independently by two reviewers using the Cochrane Collaboration risk-of-bias tool for RCTs and the Centre for Reviews and Dissemination guidance for adverse events for observational studies. A fixed-effects model was used for meta-analysis. Results We included 186 RCTs and eight observational studies across 14 surgical specialties and five reports from the regulatory bodies. Most RCTs were judged to be at an unclear risk of bias. Adverse events were inappropriately reported in observational studies. Meta-analysis across non-emergency surgical specialties did not show a statistically significant difference in the risk of seroma for fibrin sealants versus standard care in 32 RCTs analysed [ n = 3472, odds ratio (OR) 0.84, 95% confidence interval (CI) 0.68 to 1.04; p = 0.13; I 2 = 12.7%], but a statistically significant benefit was found on haematoma development in 24 RCTs ( n = 2403, OR 0.62, 95% CI 0.44 to 0.86; p = 0.01; I 2 = 0%). Adverse events related to fibrin sealant use were reported in 10 RCTs and eight observational studies across surgical specialties, and 22 RCTs explicitly stated that there were no adverse events. One RCT reported a single death but no other study reported mortality or any serious adverse events. Five regulatory body reports noted death from air emboli associated with fibrin sprays. Limitations It was not possible to provide a detailed evaluation of individual RCTs in their specific contexts because of the limited resources that were available for this research. In addition, the number of RCTs that were identified made it impractical to conduct independent data extraction by two reviewers in the time available. Conclusions The effectiveness of fibrin sealants does not appear to vary according to surgical procedures with regard to reducing the risk of seroma or haematoma. Surgeons should note the potential risk of gas embolism if spray application of fibrin sealants is used and not to exceed the recommended pressure and spraying distance. Future research should be carried out in surgery specialties for which only limited data were found, including neurological, gynaecological, oral and maxillofacial, urology, colorectal and orthopaedics surgery (for any outcome); breast surgery and upper gastrointestinal (development of haematoma); and cardiothoracic heart or lung surgery (reoperation rates). In addition, studies need to use adequate sample sizes, to blind participants and outcome assessors, and to follow reporting guidelines. Study registration This study is registered as PROSPERO CRD42015020710. Funding The National Institute for Health Research Health Technology Assessment programme." @default.
• W2571455808 created "2017-01-13" @default.
• W2571455808 creator A5041798588 @default.
• W2571455808 creator A5042988555 @default.
• W2571455808 creator A5045130941 @default.
• W2571455808 creator A5049125137 @default.
• W2571455808 creator A5063880557 @default.
• W2571455808 creator A5082198761 @default.
• W2571455808 creator A5083002515 @default.
• W2571455808 creator A5088806952 @default.
• W2571455808 date "2016-12-01" @default.
• W2571455808 modified "2023-10-10" @default.
• W2571455808 title "The use of fibrin sealant during non-emergency surgery: a systematic review of evidence of benefits and harms" @default.
• W2571455808 cites W1496844571 @default.
• W2571455808 cites W1509879630 @default.
• W2571455808 cites W1566652048 @default.
• W2571455808 cites W1582526401 @default.
• W2571455808 cites W1597755276 @default.
• W2571455808 cites W1931467626 @default.
• W2571455808 cites W1933974942 @default.
• W2571455808 cites W1964476133 @default.
• W2571455808 cites W1964972728 @default.
• W2571455808 cites W1965636480 @default.
• W2571455808 cites W1966402714 @default.
• W2571455808 cites W1967231202 @default.
• W2571455808 cites W1967564474 @default.
• W2571455808 cites W1969112722 @default.
• W2571455808 cites W1969312243 @default.
• W2571455808 cites W1969551278 @default.
• W2571455808 cites W1970668371 @default.
• W2571455808 cites W1970725802 @default.
• W2571455808 cites W1970924192 @default.
• W2571455808 cites W1975705448 @default.
• W2571455808 cites W1975800916 @default.
• W2571455808 cites W1976007738 @default.
• W2571455808 cites W1976018278 @default.
• W2571455808 cites W1976734207 @default.
• W2571455808 cites W1979273014 @default.
• W2571455808 cites W1980543978 @default.
• W2571455808 cites W1980583845 @default.
• W2571455808 cites W1980654709 @default.
• W2571455808 cites W1984085619 @default.
• W2571455808 cites W1984322784 @default.
• W2571455808 cites W1985511026 @default.
• W2571455808 cites W1986837357 @default.
• W2571455808 cites W1989044247 @default.
• W2571455808 cites W1990707700 @default.
• W2571455808 cites W1990762281 @default.
• W2571455808 cites W1994685775 @default.
• W2571455808 cites W1995176709 @default.
• W2571455808 cites W1995508438 @default.
• W2571455808 cites W1996712984 @default.
• W2571455808 cites W1996813133 @default.
• W2571455808 cites W1997721854 @default.
• W2571455808 cites W1998380304 @default.
• W2571455808 cites W1998895826 @default.
• W2571455808 cites W1999661556 @default.
• W2571455808 cites W2001120698 @default.
• W2571455808 cites W2001535692 @default.
• W2571455808 cites W2002574465 @default.
• W2571455808 cites W2003171759 @default.
• W2571455808 cites W2003541608 @default.
• W2571455808 cites W2004199519 @default.
• W2571455808 cites W2004517413 @default.
• W2571455808 cites W2004708491 @default.
• W2571455808 cites W2005090496 @default.
• W2571455808 cites W2005092132 @default.
• W2571455808 cites W2005625497 @default.
• W2571455808 cites W2006680354 @default.
• W2571455808 cites W2007285318 @default.
• W2571455808 cites W2007943384 @default.
• W2571455808 cites W2007945134 @default.
• W2571455808 cites W2009345386 @default.
• W2571455808 cites W2011233880 @default.
• W2571455808 cites W2011911961 @default.
• W2571455808 cites W2012465390 @default.
• W2571455808 cites W2013483883 @default.
• W2571455808 cites W2015221267 @default.
• W2571455808 cites W2015420963 @default.
• W2571455808 cites W2015950051 @default.
• W2571455808 cites W2016507900 @default.
• W2571455808 cites W2017895374 @default.
• W2571455808 cites W2017916326 @default.
• W2571455808 cites W2017985736 @default.
• W2571455808 cites W2018042896 @default.
• W2571455808 cites W2018114221 @default.
• W2571455808 cites W2018415105 @default.
• W2571455808 cites W2019243376 @default.
• W2571455808 cites W2021699594 @default.
• W2571455808 cites W2022729178 @default.
• W2571455808 cites W2022868570 @default.
• W2571455808 cites W2023249608 @default.
• W2571455808 cites W2024208623 @default.
• W2571455808 cites W2027008837 @default.
• W2571455808 cites W2028458036 @default.
• W2571455808 cites W2030634678 @default.
• W2571455808 cites W2032096047 @default.
• W2571455808 cites W2033302458 @default.

• next